4/A: Alpha Teknova Director Amends SEC Filing to Correct Stock Option Grant Details

Alpha Teknova, Inc. Director Alexander Vos filed an amended Form 4 to clarify that a June 17, 2025 equity grant consisted of 54,300 non-qualified stock options, not restricted stock units as previously reported.

Summary

• An amended Form 4 was filed by Alexander Vos, a Director of Alpha Teknova, Inc., to correct information in a previous filing.
• The original Form 4, filed on June 25, 2025, incorrectly reported a grant of 54,300 restricted stock units (RSUs) on June 17, 2025.
• This amended filing clarifies that the grant on June 17, 2025, was for 54,300 non-qualified stock options to purchase common stock.
• The non-qualified stock options were granted under Alpha Teknova's director compensation policy.
• The options have an exercise price of $5.39 per share.
• These options will vest on the first anniversary of the grant date, which is June 17, 2026.

Sentiment

Score: 5

Explanation: The document is a neutral administrative correction of an insider transaction. It does not contain positive or negative news about the company's operations or financial performance, but rather corrects a clerical error in a previous filing.

Positives

• The grant of 54,300 non-qualified stock options to Director Alexander Vos aligns his interests with those of the company's shareholders.
• The equity grant is part of Alpha Teknova's established director compensation policy, indicating a structured approach to incentivizing leadership.

Negatives

• The necessity of filing an amendment indicates an initial administrative error in reporting the type of securities granted.

Future Outlook

The document primarily concerns a correction to a past equity grant and does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the vesting schedule of the options.

Management Comments

• On June 25, 2025, a Form 4 was filed on behalf of the reporting person that incorrectly identified the type of securities granted to such person on June 17, 2025 as being 54,300 restricted stock units, which were included in Table I.
• This amended Form 4 is being filed to correct that the securities granted to the reporting person on June 17, 2025 were non-qualified stock options to purchase 54,300 shares of common stock, which were granted under the issuer's director compensation policy.
• These non-qualified stock options are identified on Table II and will vest on the first anniversary of the date of grant.

Industry Context

This filing is a routine disclosure of insider equity transactions, common across all publicly traded companies. It reflects standard practices for director compensation through equity grants, aiming to align director interests with shareholder value. It does not provide specific industry-wide trends or competitive insights.

Comparison to Industry Standards

• The grant of non-qualified stock options as part of director compensation is a common practice across various industries, including biotechnology and life sciences, where Alpha Teknova operates.
• Companies like Bio-Techne Corporation or Illumina, Inc. also utilize equity-based compensation to incentivize directors and executives.
• The specific size of the grant (54,300 options) and the exercise price ($5.39) would typically be evaluated against peer group compensation benchmarks, but this document does not provide sufficient data for such a detailed comparison.
• The vesting schedule of one year is also a standard practice for such grants.

Stakeholder Impact

• Shareholders: The correction ensures accurate disclosure of director equity holdings, providing transparency. The grant itself aligns director interests with shareholder value.

Next Steps

• The non-qualified stock options granted to Alexander Vos are scheduled to vest on June 17, 2026.

Key Dates

Keywords

Alpha Teknova, TKNO, SEC Form 4/A, Stock Options, Director Compensation, Beneficial Ownership, Equity Grant, Corporate Governance